Neovasc Inc. (NVCN)
(Delayed Data from NSDQ)
$0.50 USD
+0.01 (2.96%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.49 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[NVCN]
Reports for Purchase
Showing records 1 - 20 ( 33 total )
Industry: Medical - Instruments
Industry: Medical - Instruments
Industry: Medical - Instruments
Shockwave Medical Enters Into Definitive Agreement to Acquire Neovasc For $100M; Downgrading to Neutral with a $27.25 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
3Q22: Another Record-Breaking Quarter; Reiterate Buy and $20 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Strong 1H22 Accomplishments Underappreciated; Reiterate Buy Rating With PT Adjusted to $20
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Industry: Medical - Instruments
Expecting Imetelstat Clinical Programs to Make Steady Progress in 2022; Reiterate Buy Rating and $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
PECT Reimbursement Evidence of Strong Support for Reducer; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
A Meaningful Beat in 3Q21 Reducer Revenues; Reiterate Buy Rating and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Expecting Stable Reducer Growth Despite COVID-19 Challenges; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Industry: Medical - Instruments
Strong 2Q Despite COVID-19 Challenges; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Strategic Initiatives Conserve Cash and Potentially Enhance Reducer Growth; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Strength Demonstrated Against COVID-19 Headwinds; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Well-Positioned to Accelerate Growth Activities in 2021; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
We?re Positive on Strong Reducer Momentum in 2021; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Reducer Makes Important Steps in Target France Market; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
3Q20 Results Indicative of What?s Possible in a Non-COVID World; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
2Q Results and Stronger Balance Sheet Mark Growing 2H20 Momentum; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Industry: Medical - Instruments
Positive Interim Results From REDUCER-I Reinforce Sustained Therapeutic Efficacy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V